Vaxxinity Price To Sales vs. Gross Profit

VAXXDelisted Stock  USD 2.72  0.19  6.53%   
Based on the key profitability measurements obtained from Vaxxinity's financial statements, Vaxxinity may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Vaxxinity's ability to earn profits and add value for shareholders.
For Vaxxinity profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vaxxinity to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vaxxinity utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vaxxinity's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vaxxinity over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Please note, there is a significant difference between Vaxxinity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxxinity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxxinity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vaxxinity Gross Profit vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vaxxinity's current stock value. Our valuation model uses many indicators to compare Vaxxinity value to that of its competitors to determine the firm's financial worth.
Vaxxinity is rated first in price to sales category among its peers. It is rated fourth in gross profit category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vaxxinity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vaxxinity's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Vaxxinity Gross Profit vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Vaxxinity

P/S

 = 

MV Per Share

Revenue Per Share

 = 
4,605 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Vaxxinity

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
(1.87 M)
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Vaxxinity Gross Profit Comparison

Vaxxinity is currently under evaluation in gross profit category among its peers.

Vaxxinity Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vaxxinity, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vaxxinity will eventually generate negative long term returns. The profitability progress is the general direction of Vaxxinity's change in net profit over the period of time. It can combine multiple indicators of Vaxxinity, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.

Vaxxinity Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vaxxinity. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vaxxinity position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vaxxinity's important profitability drivers and their relationship over time.

Use Vaxxinity in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxxinity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxxinity will appreciate offsetting losses from the drop in the long position's value.

Vaxxinity Pair Trading

Vaxxinity Pair Trading Analysis

The ability to find closely correlated positions to Vaxxinity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxxinity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxxinity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxxinity to buy it.
The correlation of Vaxxinity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxxinity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxxinity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxxinity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vaxxinity position

In addition to having Vaxxinity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Computers Thematic Idea Now

Computers
Computers Theme
Companies that manufacture and distribute personal and business computers. The Computers theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Vaxxinity Pink Sheet

If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets